GlassScriptPhysician profile
Michael S Gutkin
NPI 1083695258
$955.53
in general payments reported to CMS, 2019-2025
12 companies · $48.01 in 2025
The $48.01 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $113 · 2021: $256 · 2022: $67.21 · 2023: $206 · 2024: $62.55 · 2025: $48.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $323.50 | 2022-2025 | |
| Abbott Laboratories | $235.23 | 2019-2021 | |
| Allergan, INC. | $124.42 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $41.69 | 2019-2022 | |
| Horizon Therapeutics Plc | $40.93 | 2019-2020 | |
| Pfizer INC. | $34.54 | 2019 | |
| Saluda Medical Americas, INC. | $34.53 | 2023 | Evoke Scs |
| Nevro Corp. | $33.33 | 2020 | |
| Bioventus LLC | $29.29 | 2019 | |
| Daiichi Sankyo INC. | $25.27 | 2019 | |
| Nalu Medical, INC. | $18.09 | 2021 | |
| Endo Pharmaceuticals INC. | $14.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gutkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.